ReviewPharmaceutics2022

A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA.

Ioana Toma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.